✦ LIBER ✦

Low self-estimated quality of life after myocardial infarction and future cardiovascular risk

✍ Scribed by Stefan Agewall; Loghman Henareh

Book ID: 116551043
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 71 KB
Volume: 157
Category: Article
ISSN: 0167-5273
DOI: 10.1016/j.ijcard.2012.03.044

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metabolic Syndrome and Risk of Cardiovas

Metabolic Syndrome and Risk of Cardiovascular Events After Myocardial Infarction

✍ G. Levantesi; A. Macchia; R. Marfisi 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 32 KB

Metabolic Syndrome and Risk of Cardiovas

Metabolic Syndrome and Risk of Cardiovascular Events After Myocardial Infarction

✍ Giacomo Levantesi; Alejandro Macchia; RosaMaria Marfisi; Maria G. Franzosi; Aldo 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Predicting quality of life and self-mana

Predicting quality of life and self-management from dyadic support and overprotection after myocardial infarction

✍ Katherine Joekes; Stan Maes; Matthijs Warrens 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Identification and management of the low

Identification and management of the low-risk patient after myocardial infarction

✍ Guy S. Reeder 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 460 KB

Coping, social support and quality of li

Coping, social support and quality of life over time after myocardial infarction

✍ Marja-Leena Kristofferzon; Rurik Löfmark; Marianne Carlsson 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

Economics and quality of life after acut

Economics and quality of life after acute myocardial infarction: Insights from GUSTO-I

✍ Daniel B. Mark 📂 Article 📅 1996 🏛 Springer US 🌐 English ⚖ 534 KB

Reperfusion therapy for acute myocardial infarction is one of the most thoroughly studied treatments in all of medicine. The GISSI-1 and ISIS-2 megatrials definitively established the superiority of intravenous streptokinase over conservative care for this condition. Tissue plasminogen activator (t-